TAVEXIA LIFECARE LIMITED Directors Report

DIRECTOR REPORT

To,

The Members,

Tavexia Lifecare Limited

(Formerly Known as Sattva Sukun Lifecare Limited)

Your directors have pleasure in presenting the 46^th Annual Report together with Audited Financial Statements of the Company for the Financial Year ended 31^st March, 2026. Further, in compliance with the Companies Act, 2013 the Company has made requisite disclosures in this Boards Report with the objective of accountability and transparency in its operations to make you aware about its performance and future perspective of the Company.

1. FINANCIAL PERFORMANCE OF THE COMPANY:

The summary of the financial performance of the Company for the year ended 31^st March, 2026 as compared to the previous year is as below:

	Amount in Lakh
Particulars	Standalone		Consolidated
	FY2026	FY2025	FY 2026	FY2025
Revenue from Operation	422.22	526.30	3224.86	526.30
Revenue from other Income	1.48	40.39	588.55	40.39
Total Revenue	423.70	566.69	3813.41	566.69
Profit after Depreciation & Interest and before Tax	2.92	318.79	16.64	318.69
Tax Expenses	-13.60	69.76	-4.53	69.74
Profit/ Loss after Tax from continuing operations	16.52	249.03	21.17	248.95

RESULT HIGHLIGHTS:

The bottom line has also shown Standalone Profit (after tax) for the year ended 31.03.2026 is Rs. 16.52 Lakhs as compared to Standalone profit of last year as on 31.03.2025 Rs. 249.03 /-. The company has consolidated profit for the year ended 31.03.2026 Rs. 21.17/- Lakhs and previous year 31.03.2025 profit of Rs. 248.95/- Lakh Further, there are no significant and material events impacting the going concern status and Companys operations in future.

Financial comparative data for March 2025 & March 2026 are as follows:

The company has indeed shown significant improvement in its profitability and growth, as evidenced by the substantial increase in both standalone and consolidated profits over the year.

• Standalone Profit: The profit declined from Rs. 249.03 lakhs in FY 2024-25 to Rs. 16.52 lakhs in FY 2025-26, primarily due to rising operational costs and unfavorable market conditions. However, management remains focused on optimizing expenses and restoring margins in the coming year.

• Consolidated Profit: The profit declined from Rs. 248.95 lakhs in FY 2024-25 to Rs. 21.17 lakhs in FY 2025-26, impacted by planned strategic investments in business expansion and capacity building. These short-term expenditures are expected to strengthen operational capabilities and drive long-term value.

This impressive growth highlights the companys successful strategies and operational efficiency, reinforcing its positive trajectory and strong financial health moving forward.

2. CHANGE IN NATURE OF B USINESS

There are no significant and material events impacting the going concern status and Companys operations in future and Our Company is under the good management guidance and control that help continued in achieving the targets of cutting down in the cost of operations and getting efficiency in this area by using better alternated resources/means. During the Year under review, there was no change in Companys Business.

3. DIVIDEND

In view of capitalization of profit for liquidity in business of funds and strong growth of company the board of directors, do not propose any dividend for the financial year ended 31st march, 2026.

4. RESERVES

The Directors have not proposed to transfer any amount to Reserves during the year.

5. CHANGE OF CAPITAL:

Authorized Share Capital of the Company: -

As on 31 March 2026, the Authorized Share Capital of the Company stands at 70,00,00,000/- (Seventy Crore) Equity Shares of face value of Re. 1/- (Rupee One Only) each aggregating to Rs. 70,00,00,000/- (Rupees Seventy Crore Only).and the Paid-up Share Capital of the Company stands at 38,36,01,248 (Thirty-Eight Crore Thirty- Six Lakh One Thousand Two Hundred Forty-Eight) Equity Shares of face value of Re. 1/- (Rupee One Only) each aggregating to Rupees 38,36,01,248 (Thirty-Eight Crore Thirty-Six Lakh One Thousand Two Hundred Forty- Eight Rupees Only)

During the Financial Year 2025-26, pursuant to the provisions of Section 62 read with Section 23(1)(c) and other applicable provisions of the Companies Act, 2013 (including rules made thereunder, as amended), and in compliance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors at its meeting held on May 05, 2025, approved the Rights Issue of equity shares.

Subsequently, the Board of Directors issued and allotted 19,16,01,248 (Nineteen Crore Sixteen Lakh One Thousand Two Hundred Forty-Eight) Equity Shares of face value Re. 1/- (Rupee One Only) each on July 07, 2025, pursuant to the said Rights Issue.

As at March 31, 2026, the paid-up equity share capital of the Company is 38,36,01,248 consisting of 38,36,01,248 equity shares of 01 each.

6. FINANCE

Cash and cash equivalent as at March 31, 2026 was Rs. 121.10/- lakhs. Against Rs. 01.29/- lakhs last year.

7. DEPOSITS

During the year under review the Company has not accepted any deposit from the public falling within the ambit of Section 73 of the Companies Act, 2013 and The Companies [Acceptance of Deposits] Rules, 2014. There was no public deposit outstanding as at the beginning and end of the financial year 2025-26.

8. BOARD OF DIRECTORS:

The Composition of the Board during the year was as per the provisions of Regulation 17 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with the Companies Act, 2013.

None of the Directors are disqualified for appointment/ re-appointment under Section 164 of the Act. Asrequired by law, this position is also reflected in the Auditors Report.

As required under Regulation 36(3) of the Listing Regulations with the stock exchanges, the information on the particulars of Directors proposed for appointment/re-appointment has been given in the notice of Annual General Meeting.

The Board at present comprises of with the following changes took place in Board of Directors and KMP of the Company During the year under review:

Sr. No	DIN	Name of Director	Designation	Original Date of Appointment	Date of Cessation
1	06520600	Mit Tarunkumar Brahmbhatt	Managing Director	14/08/2018	-
2	08415000	Khushboo Vasudev	Independent Director	31/12/2021	-
3	10477994	Mrs. Prajakta Anil Gangurde	Independent Director	27/03/2024	05/05/2025
4	10478019	Mr. Kishor Anil Kokate	Independent Director	27/03/2024	05/05/2025
5	11046372	Mr. Tanmay Paresh Shah	Independent Director	23/04/2025	-
6	11077203	Mr. Gaurav Surendra Nair	Non-Executive NonIndependent Director	05/05/2025	-
7	03471126	Mr. Sachin Bhanubhai Manseta	Independent Director	24/04/2026	-
8	08583331	Mr. Chirag Dedhia	Non-Executive NonIndependent Director	24/04/2026	-
8	ATOPR9157Q	Poonam Rani	Company Secretary & Compliance officer	28/10/2024	-
9	EIYPK2804N	Atish Ananta Kamble	CFO	01/09/2022	-

9. CHANGES IN DIRECTORS AND KEY MANAGERIAL PERSONNEL

During the year under review, there is following changes took place in Board of Directors and KMP of the Company:

Sr. No.	Name of Directors & KMP	Designation	Appointment	Resignation
1	Mrs. Prajakta Anil Gangurde	Independent Director	27/03/2024	05/05/2025
2	Mr. Kishor Anil Kokate	Independent Director	27/03/2024	05/05/2025
3	Mr. Tanmay Paresh Shah	Independent Director	23/04/2025	-
4	Mr. Gaurav Surendra Nair	Non-Executive Non-Independent Director	05/05/2025	-

Further after conclusion of F.Y. 2024-25 and before this 45th Annual General Meeting, Mrs. Prajakta Anil Gangurde (DIN: 10477994) Non-Executive - Independent Director and Mr. Kishor Anil Kokate (DIN: 10478019) Non-Executive - Independent Director of the Company resigned w.e.f. 05^th May 2025, and the board of directors appointed Mr. Tanmay Paresh Shah (DIN: 11046372) as Non-Executive Independent Director w.e.f. 23^rd April, 2025 and Mr. Gaurav Surendra Nair (DIN: 11077203) Non Executive Non Independent Director as of the Company w.e.f. 5th May, 2025.

The Shareholders of the Company approved the respective appointment of above named two Non-Executive-

Independent Directors and Non-Executive Non-Independent Director by passing Special Resolutions through EOGM on 19 th July 2025.

After closure of financial year F.Y. 2025-26, Based on the recommendations of the Nomination and Remuneration Committee (NRC) and pursuant to the provisions of the Act, the Board, at its meeting held on 24 April 2026, appointed Mr. Sachin Bhanubhai Manseta as Additional Directors in the category of Non-Executive Independent Directors, in accordance with Section 149 read with Schedule IV to the Act and applicable SEBI Listing Regulations and appointed Mr. Chirag Dedhia as Additional Directors in the category of Non-Executive Non-Independent Director.

The Shareholders of the Company approved the respective appointment of above named two Non-Executive- Independent Directors and Non-Executive Non-Independent Director by passing Special Resolutions through EOGM on 22 nd July 2026.

10. BOARD EVALUATION

Reg. 17 of SEBI (LODR) Regulations, 2015 mandates that the Board shall monitor and review the Board evaluation framework. The Companies Act, 2013 states that a formal annual evaluation needs to be made by the Board of its own performance and that of its committees and individual directors.

Schedule IV of the Companies Act, 2013 states that the performance evaluation of independent directors shall be done by the entire Board of Directors, excluding the director being evaluated. Pursuant to the provisions of section 134(3) (p) of the Companies Act, 2013 the evaluation of all the directors and the Board as a whole was conducted based on the criteria and framework adopted by the Board. The evaluation process has been explained in the corporate governance report section in this Annual Report. The Board approved the evaluation results as collated by the nomination and remuneration committee.

11. NUMBER OF MEETINGS OF THE BOARD

The Board of Directors duly meeting 08 (Eight) times respectively on 23/04/2025, 05/05/2025, 21/06/2025, 16/07/2025, 12/08/2025, 03/09/2025, 25/11/2025, 19/02/2026 in respect of which proper Notices were given and the proceedings were properly recorded and signed in the Minutes Book maintained for the purpose.

Name	Designation	DIN	Number of Board Meeting attended	Last AGM attended
Mit Tarunkumar Brahmbhatt	Managing Director	06520600	08	Yes
Khushboo Vasudev	Independent Director	08415000	07	Yes
@ Prajakta Anil Gangurde	Independent Director	10477994	01	No
@ Kishor Anil Kokate	Independent Director	10478019	01	No
Mr. Tanmay Paresh Shah #	Independent Director	11046372	07	Yes
Mr. Gaurav Surendra Nair##	Non-Executive NonIndependent Director	11077203	06	Yes

NOTE:

@Ms. Prajakta Anil Gangurde Resigned as Independent Director of the Company w.e.f. 05/05/2025.

@Mr. Kishor Anil Kokate Resigned as Independent Director of the Company w.e.f. 05/05/2025.

# Mr. Tanmay Paresh Shah appointed as Independent Director of the Company w.e.f. 23/04/2025.

## Mr. Gaurav Surendra Nair appointed as Independent Director of the Company w.e.f. 05/05/2025.

The intervening gap between any two meetings was within the period prescribed by the Companies Act, 2013.

12. POLICY ON DIRECTORS APPOINTMENT AND REMUNERATION

The current policy is to have an appropriate mix of executive and non-executive, independent directors to maintain the independence of the Board and separate its functions of governance and management.

The policy of the Company on directors appointment and remuneration, including criteria for determining qualifications, positive attributes, independence of a director and other matters provided under Subsection (3) of Section 178 of the Companies Act, 2013, adopted by the Board, are stated in this Board report. We affirm that the remuneration paid to the directors is as per the terms laid out in the nomination and remuneration policy of the Company.

13. TRAINING OF INDEPENDENT DIRECTORS

Every new independent director of the Board attended an orientation program. To familiarize the new inductees with the strategy, operations and functions of our Company, the executive directors / senior managerial personnel make presentations to the inductees about the Companys strategy, operations, product and service offerings, markets, software delivery, organization structure, finance, human resources, technology, quality, facilities and risk management.

The Company has organized the following workshops for the benefit of Directors and Independent Directors:

A program on how to review, verify and study the financial reports;

A program on Corporate Governance;

Provisions under the Companies Act, 2013; and SEBI Insider Trading Regulation, 2015.

Further, at the time of appointment of an independent director, the Company issues a formal letter of appointment outlining his/her role, functions, duties and responsibilities as a director.

14. DECLARATION BY INDEPENDENT DIRECTORS

In accordance with the provisions of Section 149(7) of the Act and Regulation 25(8) of SEBI Listing Regulations, all Independent Directors of the Company have submitted the requisite written declarations confirming that they meet the criteria of independence as prescribed under Section 149(6) of the Act and Regulation 16(1)(b) of SEBI Listing Regulations and that they are independent of the management. The Board has taken on record the said declarations after due assessment.

After closure of financial year, Mrs. Prajakta Anil Gangurde (DIN: 10477994) and Mr. Kishor Anil Kokate (DIN: 10478019) resigned from the position of Non-Executive Independent Directors of the Company with effect from May 05, 2025. The Board placed on record its sincere appreciation for their valuable guidance, support, and contributions during their respective tenures.

15. INDEPENDENT DIRECTORS DECLARATIONS:

In the opinion of the Board, the independent directors are, individually, person of integrity and possess relevant expertise and experience.

The Independent Directors under section 149(6) of the Companies Act, 2013 declared that:

1. They are not a promoter of the Company or its holding, subsidiary or associate company;

2. They are the directors in the company;

3. The independent Directors have/had no pecuniary relationship with company, its holding, subsidiary or associate company, or their promoters, or directors, during the two immediately preceding financial years or during the current financial year;

4. None of the relatives of the Independent Directors have or had pecuniary relationship or transaction with the company, its holding, subsidiary or associate company, or their promoters, or directors, amounting to two percent. or more of its gross turnover or total income or Fifty Lakhs rupees or such higher amount as may be prescribed, whichever is lower, during the two immediately preceding financial years or during the current financial year;

5. Independent Director, neither himself nor any of his relatives—

• holds or has held the position of a key managerial personnel or is or has been employee of the company or its holding, subsidiary or associate company in any of the three financial years immediately preceding the financial year in which he is proposed to be appointed;

• is or has been an employee or proprietor or a partner, in any of the three financial years immediately preceding the financial year in which he is proposed to be appointed;

• a firm of auditors or company secretaries in practice or cost auditors of the company or its holding, subsidiary or associate company; or

16. REMUNERATION OF THE DIRECTORS/KEY MANAGERIAL PERSONNEL (KMP) / EMPLOYEES:

Your Company has framed a Remuneration Policy which lays down a framework in relation to the Directors, Key Managerial Personnel and Senior Management of the Company. During the Year Company has paid remuneration to directors and KMP as follows and further details annexed in this report.

Name	Designation	Remuneration (In lakh)
Mit Tarunkumar Brahmbhatt	Managing Director	18 lakh
Atish Ananta Kamble	CFO	2 lakh
Poonam Rani	Company Secretary	3 lakh

17. INDEPENDENT DIRECTORS MEETINGS:

On 12^th January 2026, respectively the Independent Directors met privately to evaluate the performance of NonIndependent Directors, the Board, and its committees. This assessment utilized a detailed questionnaire focusing on:

? The performance of Non-Independent Directors and the Board as a whole;

? The performance of the Chairperson of the Company; and

? The quality, quantity and timeliness of information flow between the management and the Board.

The Independent Directors expressed satisfaction with the overall functioning, governance standards and effectiveness of the Board and its Committees during the Financial Year 2025-26.

18. FORMAL ANNUAL EVALUATION:

The annual evaluation process for the Board of Directors, individual Directors, and Committees was conducted in accordance with the provisions of the Companies Act and the Listing Regulations.

The Board carried out a comprehensive self-assessment, gathering input from all Directors. The evaluation focused on criteria such as board composition and structure, the effectiveness of board processes, information flow, and overall functioning.

Similarly, the performance of the Committees was assessed by the Board, taking into account feedback from committee members. The evaluation considered aspects like committee composition and the effectiveness of meetings. These criteria were largely based on the guidance note on Board Evaluation issued by the Securities and Exchange Board of India (SEBI) on January 5, 2017.

The Chairman of the Board held one-on-one meetings with Independent Directors (IDs), while the Chairman of the Nomination and Remuneration Committee (NRC) conducted individual meetings with the Executive Directors. In a separate meeting of the IDs, the performance of Non-Independent Directors, the Board as a whole, and the Chairman of the Company was evaluated, incorporating the perspectives of the Executive Director and Non-Executive Directors (NEDs).

The NRC reviewed the performance of individual Directors based on criteria such as their contribution to Board and committee meetings, preparedness on key issues, and the meaningful and constructive input they provided during discussions. The performance of the Board as a whole was also assessed.

In the subsequent Board meeting, which followed the meetings of the IDs and the NRC, the overall performance of the Board, its Committees, and individual Directors was discussed.

The evaluation process reinforced the Boards confidence in the Companys ethical standards, the cohesiveness among Board members, the Board and managements adaptability in addressing various challenges, and the openness of the management in sharing strategic information with the Board.

19. MANAGEMENT DISCUSSION & ANALYSIS

Pursuant to regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), the Management Discussion & Analysis is presented in separate section forming part of the Annual Report.

20. SHAREHOLDERS MEETINGS

The Company held its Extra-Ordinary General Meeting (EOGM) on 19^th July 2025.

The Company held its 45^th Annual General Meeting (AGM) on 30^th September 2025

The Company held its most recent Extra-Ordinary General Meeting (EOGM) on 22th July 2026.

21. CORPORATE GOVERNANCE

Our Company remains steadfast in its commitment to the highest standards of Corporate Governance, ensuring all affairs are managed with unwavering diligence, transparency, and accountability. Our governance framework is rooted in the core values of integrity, equity, and fairness, fostering long-term trust with our shareholders, employees, customers and global partner. In strict adherence to the SEBI Listing Regulations, 2015, the Company ensures timely and transparent disclosures to the Stock Exchanges. A dedicated section "Report on Corporate Governance", forming an integral part of this Annual Report, provides a comprehensive overview of our governance structures and practices along with the certificate from the Companys Secretarial Auditor i.e. M/s. Brajesh Gupta & co confirming compliance with Corporate Governance norms as stipulated in the SEBI Listing Regulations, 2015, as amended, are included in the Annual Report. Your Company continues to take proactive steps to ensure strict compliance with all evolving Corporate Governance guidelines and statutory amendments.

22. UTILISATION OF THE PROCEEDS FROM RIGHT ISSUE OF EQUITY SHARE.

During the year, there has been no deviation in the use of proceeds of the Right Issue of Equity Share from the objects stated inthe letter of offer as per Regulation 32 of SEBI Listing Regulations. The Company has been disclosing on a quarterly basis to the Audit Committee, the usage & application of proceeds of the funds raised from Right Issue and also intimate the Stock Exchange(s) on a quarterly basis, as applicable.

In terms of Regulation 32 of the Listing Regulations, there was no deviation or variation in connection with the terms of the objects mentioned in the DLOF, LOF clarification dated July 04, 2025, in respect of Right Issue of Equity Share of 19,16,01,248 number of equity shares of the Company.

Particulars	Revised Allocation (Rs. in lakhs)
1. Strategic Investment in M/s PavaPuri Export Private Limited	1000.00
2. Investment in Existing Subsidiary	200.00
3. Working Capital Requirements	220.00
4. Funding for expansion plans (acquisition of office premises, Factory & Land acquisition, New project Development etc. as mentioned in DLOF & LOF).	300.00
5. General corporate purposes	116.16
6. Issue-related expenses	80.00
Total	1916.16

The net proceeds of the Right Issue aggregating to ^19,16,01,248/- was utilized during the FY 2025-26 in accordance with the objects mentioned in the Outcome of Right Issue Committee held on Friday, 04th July, 2025. Right Issue Committee vide resolution dated March 21, 2026 approved the extension in timeline for the complete utilization of the Right Issue proceed till FY 2026-27. As on March 31, 2026 the proceeds of the Right Issue was utilized as per the objects stated in the outcome. The statement of utilization of Issue proceeds as on March 31, 2026 is provided below:

Particulars	Revised Allocation (Rs.in lakhs)	Funds Utilized Rs. In Lakhs till 31/03/2026	Funds Utilized Rs. In Lakhs till 30/06/2026
1. Strategic Investment in M/s PavaPuri Export Private Limited	1000.00	1000.00	1000.00
2. Investment in Existing Subsidiary	200.00	168.76	1194.16
3. Working Capital Requirements	220.00	220.00	220.00
4. Funding for expansion plans (acquisition of office premises, Factory & Land acquisition, New project Development etc. as mentioned in DLOF & LOF).	300.00	300.00	300.00
5. General corporate purposes	116.16	116.16	116.16
6. Issue-related expenses	80.00	55.44	61.49
Total	1916.16	1860.36	1891.81

23. CONSERVATION OF ENERGY, TECHNOLOGY, ABSORPTION, FOREIGN EXCHANGE EARNINGS AND OUTGO

A statement giving details of conservation of energy, technology absorption and foreign exchange earnings and outgo as required to be disclosed under the Act, are provided in to this report.

24. PARTICULARS OF LOAN, GUARANTEE AND INVESTMENTS UNDER SECTION 186

During the period under review, the loans, advance and guarantees if any, were provided by the Company according to limit approved by the members of the company by passing a special resolution in the shareholders meeting in compliance of the provisions of Section 186 of Companies Act, 2013.

25. PARTICULARS OF CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES UNDER SECTION 188

The particulars of contracts or arrangements with related parties referred to in Section 188(1), as prescribed in Form AOC - 2 are appended as Annexure - II.

All related party transactions that were entered into during the financial year were on an arms length basis and were in the ordinary course of business and the provisions of the Companies Act, 2013, Rules made there under and the LODR are not attracted.

All Related Party Transactions are placed before the Audit Committee and also the Board for approval. Prior omnibus approval of the Audit Committee is obtained for transactions which are foreseen and repetitive in nature. The transactions entered into pursuant to omnibus approval so granted are audited and a statement giving details of all related party transactions is placed before the Audit Committee and the Board of Directors for their approval on a quarterly basis.

The details of transactions with Related Parties are given in the notes to the Financial Statements in accordance with the Accounting Standards.

The policy on Related Party Transactions as approved by the Board is uploaded on the website of the Company at www. Mayukh.co.in &https://sattvasukun.co.in/

None of the Directors has any pecuniary relationships or transactions vis-a-vis the Company.

26. MATERIAL CHANGES AFFECTING THE FINANCIAL POSITION OF THE COMPANY

Save as mentioned elsewhere in this Report, no material changes and commitments affecting the financial position of the Company has occurred between the ends of the financial year of the Company 31^st March, 2026 till the date of this report.

27. STOCK SPLIT OF SHARES

During the year under review, the Company did not undertake any sub-division or split of its Equity Shares.

Accordingly, the authorized, share capital of the Company remained unchanged at 70,00,00,000 Equity Shares of face value L1/- (Rupees One only) each, fully paid-up.

28. CHANGE IN REGISTERED OFFICE

After closure of financial year 2025-26, the Registered Office of the Company was shifted within the local limits of Mumbai city with effect from 01 July 2026. Accordingly, the Registered Office of the Company was shifted from:

Office No. 101 On 1st Floor, Crystal Rose C.H.S Datta Mandir Road, Mahavir Nagar, Kandivali West Mumbai 400067.

To

Plot No. 2B/1, Ground Floor, Kandivali Cooperative Industrial Estate Ltd., Hindustan Naka, Kandivali (West), Mumbai - 400067.

The aforesaid change was carried out in compliance with the applicable provisions of the Act and the SEBI Listing Regulations. The necessary filings and intimations, as required, were duly made with the Registrar of Companies and Stock Exchanges.

The shifting of the Registered Office does not affect the operations, financial position, or business activities of the Company.

29. RISK MANAGEMENT POLICY

The Board of Directors of the Company are of the view that currently no significant risk factors are present which may threaten the existence of the company.

The Audit Committee and Board of Directors review these procedures periodically. The companys management systems, organizational structures, processes, standards, code of conduct and behavior together form a complete and effective Risk Management System (RMS).

30. LISTED ON STOCK EXCHANGES:

The Company is listed with BSE Limited

31. MANNER IN WHICH FORMAL ANNUAL EVALUATION HAS BEEN MADE BY THE BOARD OF ITS OWN PERFORMANCE AND THAT OF ITS COMMITTEES AND INDIVIDUAL DIRECTORS:

The annual evaluation process of the Board of Directors, individual Directors and Committees was conducted in accordance with the provisions of the Act and the Listing Regulations.

The Board evaluated its performance after seeking inputs from all the directors based on criteria such as the board composition and structure, effectiveness of board processes, information and functioning, etc.

The performance of the Committees was evaluated by the Board after seeking inputs from the committee members based on criteria such as the composition of committees, effectiveness of committee meetings, etc.

The above criteria are broadly based on the Guidance note on Board Evaluation issued by the Securities and Exchange Board of India on January 5, 2017.

The Chairman of the Board had one-on-one meetings with the IDs and the Chairman of the NRC had one-on- one meetings with the Executive and Non-Executive, Non-Independent Directors.

In a separate meeting of IDs, performance of Non-Independent Directors, the Board as a whole and the Chairman of the Company was evaluated, taking into account the views of the Executive Director and NEDs.

The NRC reviewed the performance of individual directors on the basis of criteria such as the contribution of the individual director to the Board and committee meetings like preparedness on the issues to be discussed, meaningful and constructive contribution and inputs in meetings, etc. and the Board as a whole.

In the Board meeting that followed the meeting of the IDs and meeting of the NRC, the performance of the Board, its committees and individual Directors was also discussed.

The evaluation process endorsed the Boards confidence in the ethics standards of the Company, cohesiveness amongst the Board members, flexibility of the Board and management in navigating the various challenges faced from time to time and openness of the management in sharing strategic information with the Board.

32. COMMITTEES OF THE BOARD

Currently, the Board has three committees:

1. Audit Committee,

2. Nomination and Remuneration Committee,

3. Stake Holders Relationship Committee.

A detailed note on the Board and its committees is provided under the corporate governance report section in this Annual Report.

33. AUDIT COMMITTEE

The Audit Committee is constituted in line with the regulatory requirements mandated by the Companies Act, 2013 and the Listing Obligations and Disclosure Requirements, Regulations, 2015. The details of the Committee are set as follows:

The Audit Committee met 05 (Five) times in a year 05/05/2025, 12/08/2025, 03/09/2025, 25/11/2025, 19/02/2026, ,and Composition and Attendance at Meetings of Audit Committee during the financial year ended March 31, 2026 are given in the Corporate Governance Report of the Board Reports.

> NOMINATION AND REMUNERATION COMMITTEE

Pursuant to the Act, SEBI Listing Regulations, the Company has constituted a Nomination and Remuneration Committee.

During the year under review, 05 (Five) Nomination and Remuneration Committee meeting was held on 23/04/2025 ,05/05/2025, 21/06/2025, 12/08/2025,03/09/2025 and Composition and Attendance at Meetings of Nomination & Remuneration Committee during the financial year ended March 31, 2026 are given in the Corporate Governance Report of the Board Reports

> STAKEHOLDER RELATIONSHIP COMMITTEE:

Pursuant to the Act and SEBI Listing Regulations, the Company has constituted a Stakeholders Relationship Committee. This Committee specifically looks into the grievances of the equity shareholders of the Company. During FY 2025-2026, No complaints from investors were received on any matters. The terms of reference of the Committee, inter alia, includes review of measures taken for effective exercise of voting rights by shareholders and review of adherence to the service standards in respect of various services rendered by the registrar and share transfer agent.

During the year under review, 2 (Two) Stakeholders Relationship Committee meeting was held on 05/05/2025. 03/09/2025.

34. ANNUAL RETURN:

The extract of the Annual Return pursuant to the provisions of section 92 read with Rule 12 of the Companies (Rules), 2014 is uploaded on website of company www.mayukh.co.in & https://sattvasukun.co.in/.

35. CIRCULATION OF ANNUAL REPORTS IN ELECTRONIC FORM:

The Ministry of Corporate Affairs (MCA) has exempted companies from circulation of physical copies of Annual Report for FY 2025-26. Accordingly, the Annual Report of the Company for FY 2025-26 is being sent only by email to the members, and all other persons/entities entitled to receive the same. This Annual Report, along with other documents, is also available on the Companys website at www.mayukh.co.in & https://sattvasukun.co.in/.

36. AVAILABILITY OF INFORMATION TO THE BOARD:

The board should be supplied in a timely manner with information in a form and of a quality appropriate to enable it to discharge its duties. Under the advice and direction of the chairman, the company secretarys responsibility includes ensuring good information flows within the board as well as between senior management and non-executive directors.

The following information, inter alia, is provided to the directors of the company:

- Quarterly results for the company.

- Minutes of meetings of audit committee and other committees of the board.

- General notices of interest received from directors.

- Show cause, demand, prosecution notices and penalty notices which are materially important.

- Any material default in financial obligations to and by the company.

- Any issue, which involves possible public or product liability claims of substantial nature, including any judgment or order which, may have passed strictures on the conduct of the company.

- Non-compliance of any regulatory, statutory duty.

- Legal compliance reports and details of payment of statutory dues.

- Capital budgets and any updates if required.

37. DETAILS IN RESPECT OF ADEQUACY OF INTERNAL FINANCIAL CONTROLS WITH REFERENCE TO THE FINANCIAL STATEMENTS:

The directors, have laid down internal financial controls to be followed by the company and that such internal financial controls are adequate and were operating effectively.

38. DETAILS OF SUBSIDIARY/ JOINT VENTURE/ASSOCIATE COMPANIES:

Mayukh Trading Private Limited (incorporated on 29^th October, 2021), the subsidiary of the Sattva Sukun Lifecare Limited by investment in 60 % Equity Shares of Mayukh Trading Private Limited.

The company has acquired 51% Equity stake in Pava Puri Export Private Limited on September 10, 2025.

As on 31 March 2026, the Company does not have any material subsidiary as per the Policy for Determining Material Subsidiaries, which is available on the Companys website at

In accordance with Section 129(3) of the Act, the salient features of the Financial Statements of the subsidiary company in the prescribed Form AOC-1 are annexed to this Report as Annexure I.

There is no Joint Venture or Associate Company as on 31^st March, 2026.

39. ISSUE OF EQUITY SHARES WITH DIFFERENTIAL RIGHTS:

The company has not issued any of its securities with differential rights during the year under review.

40. AUDITORS & THEIR REPORTS:

A. Statutory Auditors:

The Members of the Company at the 43rd Annual General Meeting held on 29/09/2023 approved the appointment of SSRV & Associates, Chartered Accountants (Firm Registration No. 135901W), as the Statutory Auditors of the Company for a term of five years] commencing from the conclusion of the 43rd Annual General Meeting until the conclusion of the 48th Annual General Meeting.

SSRV & Associates have confirmed their eligibility under Sections 139 and 141 of the Companies Act, 2013 and the rules framed thereunder. The Board places on record its appreciation for the services rendered by the outgoing auditors during their tenure

The Standalone & consolidated Auditors Report and the Notes on financial statement for the year 2025-26 referred to in the Auditors Report are self-explanatory and does not contain any qualification, reservation or an adverse remark, therefore, do not call for any further comments.

The Board took note of the resignation letter dated 07th September, 2026 received from M/s SSRV & Associates, Chartered Accountants, [Firm Registration No. 135901W], Statutory Auditors of the Company, resigning from the office of Statutory Auditors of the Company with effect from 07th September, 2026. The Board considered and accepted the resignation of M/s SSRV & Associates and placed on record its appreciation for the services rendered by the firm during its tenure as Statutory Auditors of the Company.

The Board considered and approved the appointment of M/s DEVAM & Associates LLP, Chartered Accountants, [Firm Registration No. 139355W/W100925], as the Statutory Auditors of the Company in place of M/s SSRV & Associates Statutory Auditors of the company due to resignation, subject to the approval of the members of the Company at the upcoming General Meeting, in accordance with the applicable provisions of the Companies Act, 2013.

B. Secretarial Audit Renort:

Pursuant to Regulation 24A of the SEBI Listing Regulations, the Company has approved the appointment of M/s. Brajesh Gupta & co, Practicing Company Secretaries, Peer Reviewed Practicing Company Secretaries, as the Secretarial Auditor of the Company for a term of five (5) consecutive financial years, commencing from Financial Year 2025-26 to Financial Year 2029-30, at the previous Annual General Meeting of the Company.

In compliance with the provisions of Section 204 of the Companies Act, 2013 read with the Rules made thereunder, the Board of Directors appointed M/s. Mr. Brajesh Gupta & co, Practicing Company Secretaries, Indore (Mem No: 33070 & COP: 21306) as the Secretarial Auditor of the Company to conduct the Secretarial Audit of the records, registers, and documents of the Company for the Financial Year 2025-26 to Financial Year 2029-30.

The Secretarial Auditors have submitted their report as provided under Annexure- III to this Boards Report, confirming compliance by the Company of all the provisions of applicable laws.

The Secretarial Audit Report contains observation remarks as follow.

The company has delayed filed following forms to ROC:-

Sr. No. Name of Form	Purpose
1 Form No. CHG-1	Registration of creation of charge

- The management of the Company has informed that delay submission of form above form due to technical issues on MCA website and the companys secretarial team after coordination with MCA help desk could file the said forms with delay/additional fees.

During the period under review, the Company approved and submitted its Unaudited Financial Results for the quarter and half-year ended September 30, 2025, and the quarter ended December 31, 2025, beyond the statutory timeline of 45 days. The said financial results were subsequently approved by the Board of Directors at its meetings held on November 25, 2025, and February 19, 2026, respectively, resulting in non-compliance with Regulation 33(3)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

1. For the Quarter Ended September 30, 2025: The delay was unintentional and arose from the corporate acquisition of Pavapuri Export Private Limited. Converting standalone entries into consolidated financials, aligning disparate accounting policies, and finalizing consolidated audits required critical additional execution time. The Board subsequently approved the results on November 25, 2025.

2. For the Quarter Ended December 31,2025: The scheduled Board Meeting on February 14, 2026, lacked the requisite statutory quorum and had to be adjourned. The meeting safely reconvened on February 16, 2026, to finalize, approve, and submit the financial statements.

The corresponding fines levied by BSE Limited have been settled in full. The Management has enhanced its internal corporate accounting and secretarial schedules to ensure absolute, uninterrupted compliance with listing timelines moving forward.

Observation in respect with Regulation 46 of SEBI (LODR) Regulations, 2015 Regarding Corporate Website: Technical Gap in Website Functionality Due to Third-Party Service Provider Default

Your Directors clarify that the temporary downtime of the corporate website was entirely due to an external cybersecurity incident at the level of our third-party web hosting service provider:

• The Incident: On May 7, 2026, the provider reported a sophisticated cyberattack exploiting a critical cPanel/WHM zero-day vulnerability. Despite the providers patches, the attacker caused severe damage, including deleting database server data and historical backups, making full data restoration difficult.

• Company Impact: This incident occurred strictly at the external vendors level. The Companys internal IT infrastructure remains completely unaffected and secure.

• Precautionary Measures: As a safeguard, the corporate website was temporarily taken offline, causing a technical gap in online listing disclosures. Evaluation of the data impact is ongoing in coordination with the provider.

The Company has approved its annual audited financial results for the financial year ended 31st March, 2026 beyond 60 days i.e. in the meeting held on 4th June, 2026. There was contravention of Regulation 33(3)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR Regulations);

The Management informed that due to non-completion of audit procedures, including completion of ledger confirmations and finalization of audit processes, the Audited Financial Results could not be approved by the Board and submitted within prescribed timelines. The Company represented that the same was submitted upon completion of the audit process.

c. Internal Audit Report:

The Company has appointed Internal Auditor of the company in terms of section 138 of the Companies Act, 2013 for the financial year 2025-26 and internal Auditorhas conducted the audit for F.Y. 2025-26 Auditors Report are self-explanatory and does not contain any qualification, reservation or an adverse remark, therefore, do not call for any further comments.

d. Cost Auditors

Appointment of Cost Auditor is not applicable to the Company. Hence, the company has not appointed any Cost Auditor and cost accounts and records are not required to maintain by the company.

During the year under review, the Statutory Auditor and Secretarial Auditor have not reported any instances of frauds Committed in the Company by its Officers or Employees, to the Audit Committee under Section 143(12) of the Act details of which needs to be mentioned in this Report

41. ADOPTION OF INDIAN ACCOUNTING STANDARD (IND AS)

The Ministry of Corporate Affairs vide notification dated 16 February 2015 made it mandatory in a phased manner for adoption and applicability of Indian Accounting Standards (Ind AS) for companies other than Banking, Insurance and Non-Banking Finance Companies. Rule 4 of the Companies (Indian Accounting Standards) Rules 2015 specifies the classes of companies which shall comply with the Ind AS in preparation of the financial statements. In accordance with clause (iii) of sub rule (1) of the Rule 4 of the companies (Indian Accounting Standards) Rules 2015, the compliance of Indian Accounting Standards was applicable and mandatory to the company for the accounting period beginning from 1 April 2017.

The financial statements for the year under review have been prepared in accordance with the Ind AS including the comparative information for the year ended 31 March 2026 as well as the financial statements on the date of transition i.e. 1 April 2016

42. PREVENTION OF SEXUAL HARASSMENT OF WOMEN AT WORK PLACE

The Company has zero tolerance for sexual harassment at workplace and has adopted a Respect for Gender Policy on prevention, prohibition and redressal of sexual harassment in line with the provisions of the Sexual Harassment of Women at Workplace [Prevention, Prohibition and Redressal] Act, 2013 and the Rules framed there under.

As per the requirement of Sexual Harassment of Women at the Workplace (Prevention, Prohibition and Redressal) Act, 2013, (POSH) your Company has a robust mechanism in place to redress the complaints reported under this Act. The Company has complied with provisions relating to the constitution of Internal Complaints Committee (ICC) under POSH. The Internal Complaints Committee (ICC) composed of internal members and an external member who has extensive experience in the relevant field. The said Committee meets regularly and takes up programs to spread awareness and educate employees about prevention of Sexual Harassment at Workplace

The Company has not received any written complaint on sexual harassment during the financial year.

A. Number of complaint filed during the financial year 2025-26:	NIL
B. Number of complaint disposed during the financial year 2025-26:	NIL
C. Number of complaint pending as on end of the financial year 2025-26:	NIL

Maternity Benefit Compliance,

The Company hereby confirms that it has duly complied with the provisions of the Maternity Benefit Act, 1961 and the rules made thereunder, including the provision of maternity leave and benefits to eligible women employees, as applicable during the financial year 2025-26.

Number of female employees availing maternity benefits: Nil Maternity leave policies and enhancements:-Yes

Provision of creche facilities (as per the Maternity Benefit (Amendment) Act, 2017, if applicable):Yes

GENDER-WISE COMPOSITION OF EMPLOYEES

In alignment with the principles of diversity, equity, and inclusion (DEI), the Company discloses below the gender composition of its workforce as on the March 31, 2026.

Male Employees: 8 Female Employees: 3 Transgender Employees: 0

This disclosure reinforces the Companys efforts to promote an inclusive workplace culture and equal Opportunity for all individuals, regardless of gender

43. RISK MANAGEMENT POLICY:

The Board of Directors of the Company are of the view that currently no significant risk factors are present which may threaten the existence of the company.

During the year, your Directors have an adequate risk management policy in place capable of addressing those risks. The company manages monitors and reports on the principal risks and uncertainties that can impact its ability to achieve its strategic objectives. The Audit Committee and Board of Directors review these procedures periodically. The companys management systems, organizational structures, processes, standards, code of conduct and behavior together form a complete and effective Risk Management System (RMS).

44. CORPORATE SOCIAL RESPONSIBILITY (CSR)

We view responsible conduct as a necessary input for long term business success. We accept responsibility for our business, or employees and society. That is how we define our corporate responsibility. But as per Section 135 of Companies Act, 2013 your company is out of the preview of this responsibility.

45. CODE OF CONDUCT

The Board of Directors has approved a Code of Conduct which is applicable to the members of the Board and all employees in the course of day to day business operations of the company. The Company believes in "Zero Tolerance" against bribery, corruption and unethical dealings / behaviors of any form and the Board has laid down the directives to counter such acts. The Code has been posted on the Companys website.

The Code lays down the standard procedure of business conduct which is expected to be followed by the Directors and the designated employees in their business dealings and in particular on matters relating to integrity in the work place, in business practices and in dealing with stakeholders. The Code gives guidance through examples on the expected behavior from an employee in a given situation and the reporting structure.

All the board members and the senior management personnel have confirmed compliance with the code. All management staff were given appropriate training in this regard. The declaration on Code of Conduct is annexed as Annexure - V.

46. VIGIL MECHANISM / WHISTLE BLOWER POLICY

The Company has a Whistle Blower Policy to deal with instances of fraud and mismanagement, if any. The details of establishment of such mechanism have been disclosed on the website.

Pursuant to Section 177(9) of the Act, a vigil mechanism was established for directors and employees to report to the management instances of unethical behaviour, actual or suspected, fra ud or violation of the Companys code of conduct or ethics policy. The Vigil Mechanism provides a mechanism for employees of the Company to approach the Chief Ethics Counsellor / Chairman of the Audit Committee of Directors of the Company for Redressal. No person has been denied access to the Chairman of the Audit Committee of Directors.

The Company has adopted a Whistleblower Policy and Vigil Mechanism to provide a formal mechanism to the Directors, employees and its stakeholders to report their concerns about unethical behavior, actual or suspected fraud or violation of the Companys Code of Conduct or Ethics Policy. Protected disclosures can be made by a whistleblower through several channels. The policy provides for adequate safeguards against victimization of employees who avail of the mechanism and also provides for direct access to the Chairman of the Audit Committee. It is affirmed that no personnel of the Company have been denied access to the Audit Committee.

47. PREVENTION OF INSIDER TRADING

The Company has adopted a Code of Conduct for Prevention of Insider Trading with a view to regulate trading in securities by the directors and designated employees of the Company. The Code requires pre- clearance for dealing in the Companys shares and prohibits the purchase or sale of company shares by the directors and the designated employees while in possession of unpublished price sensitive information in relation to the company and during the period when the trading window is closed. The Board is responsible for implementation of the Code.

All Board of Directors and the designated employees have confirmed compliance with the Code.

48. SIGNIFICANT AND MATERIAL ORDERS

There are no significant and material orders passed by the regulators or courts or tribunals impacting the going concern status and Companys operations in future. The Company confirms that it is not involved in any material litigation as on the date of this Report.

49. CFO CERTIFICATION

The Chief Financial Officer Certification as required under Regulation 17(8) read with Part B of Schedule II of the SEBI (LODR) Regulation, 2015 have been appended to this report in Annexure- VI.

50. PARTICULARS OF EMPLOYEES AND RELATED INFORMATION

In terms of the provisions of Section 197(12) of the Act read with Rule 5 of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, a statement containing the disclosures pertaining to remuneration and other details as required under the Act and the above Rules are provided in the Annual Report. The disclosures as specified under Rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014. Attached as Annexure - ANNEXURE-II.

51. INTERNAL FINANCIAL CONTROL AND ITS ADEQUACY.

The Board has adopted policies and procedures for ensuring the orderly and efficient conduct of its business, including adherence to the companys policies, the safeguarding of its assets, the prevention and detection of frauds and errors, the accuracy and completeness of the accounting records, and the timely preparation of reliable financial disclosures. Companies declare that their accounting software has:

• Non-deletable audit trail

• Daily backups stored in office

52. INTERNAL FINANCIAL CONTROL

The Company has in place adequate internal financial control with reference to financial statements. During the year, such controls were tested and no reportable material weakness in designs or operations were observed.

53. DIRECTORS RESPONSIBILITY STATEMENT

Pursuant to Section 134(5) of the Companies Act, 2013, your Directors confirm that—

(a) In the preparation of the annual accounts, the applicable accounting standards had been followed along with proper explanation relating to material departures.

(b) The directors have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the company at the end of the financial year and of the profit and loss of the company for that period;

(c) The directors have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of the company and for preventing and detecting fraud and other irregularities;

(d) The directors have prepared the annual accounts on a going concern basis;

(e) The directors, have laid down internal financial controls to be followed by the company and that such internal financial controls are adequate and were operating effectively, and

(f) The directors have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.

54. DETAILS OF APPLICATION MADE OR PROCEEDING PENDING UNDER INSOLVENCY AND BANKRUPTCY CODE 2016:

During the year under review, there were no applications made or proceeding pending in the name of the company under the Insolvency Bankruptcy Code, 2016.

55. DETAILS OF DIFFERENCE BETWEEN VALUATION AMOUNT ON ONE TIME SETTLEMENT AND VALUATION WHILE AVAILING LOAN FROM BANKS AND FINANCIAL INSTITUTIONS:

During the year under review, there has no one-time settlement of Loans taken from Banks and Financial Institutions.

56. TRANSFER OF UNCLAIMED DIVIDEND TO INVESTOR EDUCATION AND PROTECTION FUND:

The provisions of Section 125(5) of the Companies Act, 2013 do not apply on the company as no dividend has been declared during the year.

57. REPORTING OF FRAUDS:

There was no instance of fraud during the year under review, which required the Statutory Auditors to report to the Audit Committee and/or Board under Section 143(12) of the Act and Rules framed there under.

58. SUSPENSE ACCOUNT/UNCLAIMED SUSPENSE ACCOUNT:

The Company does have outstanding shares in the suspense account and is required to maintain any Suspense Account or Unclaimed Account as required under Schedule V of SEBI (LODR).

As per Schedule V of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the details of equity shares lying in the Unclaimed Suspense Account of the Company are as under

Particulars	Number of Shareholders	Number of Equity Shares
Aggregate number of shareholders and outstanding shares lying at the beginning of the year	0	0
Number of shareholders who approached the Company for transfer of shares from suspense account during the year	0	0
Number of shareholders to whom shares were transferred from suspense account during the year	1	617199
Aggregate number of shareholders and outstanding shares lying at the end of the year *	1	617199

*the shares laying in the Mayukh Deal Trade Limited Physical Bonus Issue Unclaimed Suspense Escrow account due to bonus issue.

59. SWEAT EQUITY, & EMPLOYEE STOCK OPTION PLAN:

The company has neither issued sweat equity nor has provided any stock option scheme to the employees.

60. RIGHTS ISSUE OF EQUITY SHARES

During the financial year under review, your Company undertook a fund-raising exercise through a Rights Issue to strengthen its financial position and support business growth.

The Board of Directors, at its meeting held on January 25, 2025, approved the proposed Rights Issue aggregating up to ^49.50 Crores and approved the Draft Letter of Offer. Subsequently, the Company received In-principle Approval from BSE Limited vide its letter dated March 27, 2025.

Further, the Board of Directors / Rights Issue Committee, at its meeting held on May 05, 2025, finalized the issue terms, approving a fundraise target of up to ^48.00 Crores through the issuance of up to 48,00,00,000 Equity Shares of face value of Re. 1/- each at an issue price of Re. 1/- per Rights Equity Share.

Against the finalized issue size, the Company received valid subscriptions amounting to ^19,16,01,248/- (net of rejected/invalid applications). Your Directors are pleased to report that the Promoters of the Company fully fulfilled their commitment towards subscription to the Rights Issue.

The Rights Issue Committee, at its meeting held on July 04, 2025, took note of the actual subscription received and approved the revised allocation/utilization of the issue proceeds. Consequently, the Board/ Committee, at its meeting held on July 07, 2025, approved the allotment of 19,16,01,248 fully paid-up Equity Shares of face value of Re. 1/- each at an issue price of Re. 1/- per Equity Share to eligible shareholders and/or renouncee(s). The entire process was completed in strict compliance with the applicable provisions of the Companies Act, 2013, the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

61. MAJOR EVENTS AND CHANGES DURING THE YEAR:

During the year under review, major events occurred during the F.Y. 2025-2026 as under: -

Sattva Sukun Lifecare Limited initiated a rights issue in early 2025, securing board approval on January 25 and BSE in-principle approval on March 27 for a proposed ^49.50 crore raise. On May 5, 2025, the terms were finalized to raise up to ^48 crore through 48 crore shares at Re. 1 per share. The issue concluded with ^19.16 crore in valid subscriptions, with the board approving the allotment of 19,16,01,248 fully paid-up shares on July 7, 2025, following a revised allocation plan.

During the year under review, the Company expanded its business footprint into trading by executing a strategic corporate acquisition. Following approval from the Rights Issue Committee on July 04, 2025, and subsequent shareholder approval via a Special Resolution passed at the Extraordinary General Meeting (EGM) on July 19, 2025, the Company completed the acquisition on September 10, 2025. The Company invested ^10,00,00,000/- to acquire 10,410 Equity Shares of face value ^10/- each, representing exactly 51% of the total paid-up equity share capital of M/s Pavapuri Export Private Limited. Consequent to this transaction, M/s Pavapuri Export Private Limited became a Subsidiary Company of the Company with effect from September 10, 2025.

Subsequent to the closure of the financial year under review, the Company initiated a corporate rebranding exercise to change its name from Sattva Sukun Lifecare Limited to Tavexia Lifecare Limited, along with consequential alterations to the Memorandum of Association (MoA) and Articles of Association (AoA). The Board of Directors approved the proposed name change at its meeting held on June 30, 2026, which was subsequently approved by the shareholders via a Special Resolution passed at the Extraordinary General Meeting (EGM) held on July 22, 2026. The necessary applications have been filed with BSE Limited and the Registrar of Companies (RoC), and the final approval and issuance of the Fresh Certificate of Incorporation from the respective authorities are currently pending.

62. ACKNOWLEDGEMENTS:

Your Directors would like to acknowledge and place on record their sincere appreciation to all Stakeholders, Clients, Financial Institutions, Banks, Central and State Governments, the Companys valued investors and all other business partners for their continued co-operation and excellent support received during the year.

Your Directors recognize and appreciate the efforts and hard work of all the employees of the Company and their continued contribution to its growth.

By Order of the Board
For Tavexia Lifecare Limited
(Formerly Sattva Sukun Lifecare Ltd.)
Sd/-	Sd/-
Mit Tarunkumar Brahmbhatt	Tanmay Paresh Shah
Managing Director	Director
DIN:06520600	DIN:11046372
Date: 07th September, 2026
Place: Mumbai